seattle genetics

Three leading biotech companies will step into the earnings spotlight this week. Consensus forecasts from Wall Street analysts call for earnings growth from just two of them. And only one of them has topped estimates by double-digits in recent quarters. While the biotechnology industry has had a...

Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of both of these stocks rose sharply during the two-week period. Short sellers shied away from many of the...

Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of one of those two stocks slumped more than 22 percent during the period. Short sellers shied away from many of...

Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out as leaders of that trend in those two weeks. Shares of one of those two stocks rose while the other slumped during the period. Short sellers moved on only a few of the leading...

Short interest in many leading biotech stocks declined in the most recent period. Bucking that trend is a biotech company that soon will be acquired by an overseas peer. Short sellers retreated most sharply from a biotech that some analysts now see as a value stock. Between the March 31 and April...

The three largest biotechs are set to share their latest quarterly results this week. Wall Street analysts are looking for solid to strong growth from all three. However, expectations are lower for many other biotech and pharmaceutical companies reporting this week. The three largest public...

Insiders continue to snap up seeming bargains, even with the markets on the rise. Three biotech companies saw notable insider purchases recently. Strong insider buying is often considered a positive sign for investors, particularly during volatile periods. While the markets may be up from their...

Insiders continue to snap up seeming bargains, even as the markets perk up. Three biotech companies saw notable insider purchases recently. Strong insider buying is often considered a positive sign for investors, particularly during volatile periods. While things may be starting to...

Short interest moves in leading biotech stocks were mixed in the most recent period. However, Illumina, Inc. (NASDAQ: ILMN) and Baxalta Inc (NYSE: BXLT) saw sharp increases in their short interest in late November. Short sellers appeared to lose interest in Juno Lighting LLC (NASDAQ: JUNO) late in...

Short interest changes in biotech stocks were mixed during the most recent period. Baxalta Inc (NYSE: BXLT) and Juno Therapeutics Inc (NASDAQ: JUNO) saw short interest surges in late September. Short interest in Medivation Inc (NASDAQ: MDVN) plunged during that time. With the ongoing market...

Insiders have been taking advantage of recent volatility to scoop up shares. CEOs at American Eagle Outfitters, Sears Holdings and Hess have been among the notable buyers. Strong insider buying is often taken as a positive sign for investors. Tuesday's sell-off was another...

Even with volatility having returned to the markets, insider buying of stocks remains strong of late, particularly among certain energy players. Diamond Offshore Drilling, Kinder Morgan and Seattle Genetics were among those that have seen significant insider buys recently. Insiders may sell shares...

Even with markets reaching for record highs, insider buying has remained strong of late. American Express, General Electric and Sprint were among those that have seen significant insider buys in the past week or so. Insiders may sell shares for any number of reasons, but conventional wisdom...

Kinder Morgan, Seattle Genetics and Target are among the companies that have seen insider buying recently. Insiders may sell shares for any number of reasons, but conventional wisdom says that insiders really only buy shares of a company for one reason -- they believe the stock price will rise and...

The earnings crunch continues this week. Among the highlights will be scheduled quarterly reports from Exxon Mobil and Chevron, from Bristol-Myers Squibb and Merck, from Time Warner and Viacom, and also from Twitter. Early Thursday, Exxon Mobil (NYSE: XOM) is expected to say that it had earnings...